Additionally, BCP has been observed to attenuate neuronal necrosis and the expression of receptor-interaction protein kinase-1 (RIPK1), receptor-interaction protein kinase-3 (RIPK3) and mixed-lineage kinase domain-like protein (MLKL) in cerebral ischemia. This evidence concerns the gene MLKL and brain ischemia.